文献
J-GLOBAL ID:202202231063629624
整理番号:22A0648867
フルクトース-1,6-ビスホスファターゼ阻害剤としての新規インドール誘導体の発見とX線結晶構造解析【JST・京大機械翻訳】
Discovery of Novel Indole Derivatives as Fructose-1,6-bisphosphatase Inhibitors and X-ray Cocrystal Structures Analysis
著者 (14件):
Wang Xiaoyu
(Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Zhao Rui
(Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Zhao Rui
(School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Ji Wenming
(State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Ji Wenming
(Diabetes Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Zhou Jie
(Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Liu Quan
(State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Liu Quan
(Diabetes Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Zhao Linxiang
(School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Shen Zhufang
(State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Shen Zhufang
(Diabetes Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Liu Shuainan
(State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Liu Shuainan
(Diabetes Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
,
Xu Bailing
(Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China)
資料名:
ACS Medicinal Chemistry Letters
(ACS Medicinal Chemistry Letters)
巻:
13
号:
1
ページ:
118-127
発行年:
2022年
JST資料番号:
W5043A
ISSN:
1948-5875
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)